ScholarIQanswers from OpenAlex & ORCID
Kunio Okamoto
ResearcherPublications, citations & collaboration network
Kunio Okamoto is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kunio Okamoto have?
ScholarIQindexed works
Kunio Okamoto has 282 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kunio Okamoto have?
ScholarIQcitation count
Kunio Okamoto has 2,297 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kunio Okamoto?
ScholarIQh-index
Kunio Okamoto has an h-index of 23 in OpenAlex.
What is the i10-index of Kunio Okamoto?
ScholarIQi10-index
Kunio Okamoto has an i10-index of 73 in OpenAlex.
What is the ORCID of Kunio Okamoto?
ScholarIQorcid
The ORCID for Kunio Okamoto is on the source record.
What is the OpenAlex record for Kunio Okamoto?
ScholarIQopenalex
The OpenAlex for Kunio Okamoto is on the source record.
What are the most-cited papers on Kunio Okamoto?
ScholarIQmost cited works
Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection
Yasuhiro Kidera, Hisato Kawakami, Tsutomu Sakiyama, Kunio Okamoto, Kaoru Tanaka, Masayuki Takeda, Hiroyasu Kaneda, Shinichi Nishina, Junji Tsurutani, Kimiko Fujiwara, Morihiro Nomura, Yuzuru Yamazoe, Yasutaka Chiba, Shozo Nishida, Takao Tamura, Kazuhiko Nakagawa
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
Junko Tanizaki, Isamu Okamoto, Kunio Okamoto, Ken Takezawa, Kiyoko Kuwata, Haruka Yamaguchi, Kazuhiko Nakagawa
Role of Survivin in EGFR Inhibitor–Induced Apoptosis in Non–Small Cell Lung Cancers Positive for <i>EGFR</i> Mutations
Kunio Okamoto, Isamu Okamoto, Wataru Okamoto, Kaoru Tanaka, Ken Takezawa, Kiyoko Kuwata, Haruka Yamaguchi, Kazuto Nishio, Kazuhiko Nakagawa
The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
Hisato Kawakami, Isamu Okamoto, Kimio Yonesaka, Kunio Okamoto, Kiyoko Shibata, Yume Shinkai, Haruka Sakamoto, Michiko Kitano, Takao Tamura, Kazuto Nishio, Kazuhiko Nakagawa
Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin
Kunio Okamoto, Isamu Okamoto, Erina Hatashita, Kiyoko Kuwata, Haruka Yamaguchi, Aya Kita, Kentaro Yamanaka, Mayumi Ono, Kazuhiko Nakagawa